Holen Sie sich die Stockscreener-App
92.18
0.29%
0.27
Handel nachbörslich:
92.01
-0.17
-0.18%
Schlusskurs vom Vortag:
$91.91
Offen:
$92
24-Stunden-Volumen:
412.34K
Relative Volume:
0.76
Marktkapitalisierung:
$3.02B
Einnahmen:
$2.32B
Nettoeinkommen (Verlust:
$82.93M
KGV:
36.58
EPS:
2.52
Netto-Cashflow:
$203.54M
1W Leistung:
+0.22%
1M Leistung:
+9.13%
6M Leistung:
-5.55%
1J Leistung:
-2.73%
1-Tages-Spanne:
$92.00
$92.64
1-Wochen-Bereich:
$91.56
$92.64
52-Wochen-Spanne:
$82.15
$98.95
Amedisys Inc Stock (AMED) Company Profile
Firmenname
Amedisys Inc
Sektor
Branche
Telefon
(225) 292-2031
Adresse
3854 AMERICAN WAY, BATON ROUGE, LA
Vergleichen Sie AMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
92.18 | 3.02B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
318.47 | 80.67B | 69.62B | 5.93B | 5.88B | 22.27 |
|
DVA
Davita Inc
|
169.97 | 14.91B | 12.67B | 827.68M | 1.42B | 9.27 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.09 | 13.55B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
134.43 | 13.13B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
188.78 | 12.45B | 15.42B | 1.03B | 956.84M | 15.02 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Herabstufung | Truist | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Herabstufung | UBS | Neutral → Sell |
| 2022-06-29 | Eingeleitet | Stifel | Hold |
| 2022-06-21 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Hochstufung | UBS | Sell → Neutral |
| 2022-02-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-25 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Raymond James | Outperform |
| 2022-02-25 | Bestätigt | Truist | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-10 | Bestätigt | The Benchmark Company | Buy |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Fortgesetzt | Barclays | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Buy |
| 2020-06-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Eingeleitet | Credit Suisse | Outperform |
| 2019-11-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2019-09-17 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Eingeleitet | Barclays | Equal Weight |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-10-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Bestätigt | Mizuho | Buy |
| 2017-11-02 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Eingeleitet | BofA/Merrill | Neutral |
Alle ansehen
Amedisys Inc Aktie (AMED) Neueste Nachrichten
Oak Thistle LLC Purchases 3,440 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Home Care Service Market Set to Witness Significant Growth, 2025-2032 | Amedisys Inc, LHC Group, Brookdale - EIN News
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
UnitedHealth, Amedisys ask judge to toss antitrust lawsuit - Modern Healthcare
Amedisys halts deal to divest more than 100 home health centers - The Advocate
Amedisys cancels sale of home health centers to VCG Luna - Investing.com India
Amedisys cancels sale of home health centers to VCG Luna By Investing.com - Investing.com South Africa
UnitedHealth Wants $3.3B Amedisys Deal Challenge Tossed - Law360
UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring - The Wall Street Journal
UnitedHealth Says US Hiding Key Info in Suit Over Amedisys Deal - Bloomberg Law
Amedisys Inc filed SEC Form 8-K: Other Events - Quantisnow
VitalCaring Deal Reportedly Suspended As UnitedHealth, Amedisys Seek Path Forward - Home Health Care News
[UPDATED] Amedisys Halts Sale of Home Health, Hospice Locations to VitalCaring - Hospice News
UnitedHealth, Amedisys delay close date of $3.3B merger - Healthcare Dive
DOJ Wants Oct. Amedisys Trial, UnitedHealth Wants Aug. - Law360
Hospital-At-Home Market Top PlayersAmedisys, Aurora - openPR
Principal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Principal Financial Group Inc. Reduces Stock Position in Amedisys, Inc. (NASDAQ:AMED) - Defense World
UnitedHealth, Amedisys Stocks In Focus As $3.3B Merger Deadline Extended Amid DOJ Wrangling: Retail Guarded - MSN
President and CEO Ashworth Richard M covered exercise/tax liability with 11,079 shares, decreasing direct ownership by 10% to 101,609 units (SEC Form 4) - Quantisnow
Chief Legal Officer Griffin Jennifer G covered exercise/tax liability with 3,507 shares, decreasing direct ownership by 20% to 14,000 units (SEC Form 4) - Quantisnow
Amedisys stock holds as merger deal with UnitedHealth extended By Investing.com - Investing.com Nigeria
Amedisys shares retain Outperform rating with analyst highlighting UNH acquisition alignment - Investing.com Nigeria
Death Care Market Projected To Witness Substantial Growth, 2024-2031:Carriage Services, Inc., Amedisys, Inc. - EIN News
Death Care Market Projected To Witness Substantial Growth, 2024-2031:Carriage Services, Inc., Amedisys, Inc. Dignity PLC - WICZ
UnitedHealth, Amedisys extend deadline for M&A deal - The Business Journals
Short Interest in Amedisys, Inc. (NASDAQ:AMED) Decreases By 14.7% - MarketBeat
UnitedHealth, Amedisys waive right to terminate merger pact - Yahoo Finance
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger - MSN
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal - MSN
UnitedHealth, Amedisys Move Ahead With New Waiver To Complete $3.3 Billion Deal - Home Health Care News
Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More - MSN
Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal - MSN
Stocks fall, Amedisys deal extension, Netflix-NFL record: Market Minute - Yahoo Finance
Amedisys (NASDAQ:AMED) Shares Gap UpWhat's Next? - MarketBeat
Amedisys and UnitedHealth Extend Merger DeadlineWhat's Going On? - Benzinga
Amedisys Sees Unusually Large Options Volume (NASDAQ:AMED) - MarketBeat
UnitedHealth, Amedisys extend window to finish $3.3B deal - Modern Healthcare
UnitedHealth and Amedisys extend $3.3B merger deadline amid DOJ scrutiny - Proactive Investors USA
UnitedHealth, Amedisys Extend Window to Complete Deal - Yahoo Finance
Amedisys and UnitedHealth amend merger agreement terms - Investing.com India
Amedisys and UnitedHealth amend merger agreement terms By Investing.com - Investing.com South Africa
UnitedHealth: deadline extended for merger with Amedisys - Marketscreener.com
UnitedHealth (UNH), Amedisys (AMED) Extend Window to Finish $3.3 Billion Deal - Bloomberg
Merger Drama: UnitedHealth-Amedisys Waive Termination Rights, Face DOJ Hurdles with Extended Deal - Yahoo Finance
UnitedHealth, Amedisys extend merger deadline amid DOJ scrutiny By Investing.com - Investing.com Canada
UnitedHealth, Amedisys Extend $3.3B Deal Deadline - Newsmax
Finanzdaten der Amedisys Inc-Aktie (AMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):